Mark Walport, Mike Dexter, Todd Golub | GenomeWeb

Mark Walport has been appointed as the new director of the UK’s Wellcome Trust. He succeeds Mike Dexter, who retires from the Trust at the end of March following a five-year term as director. Walport is currently head of the division of medicine at Imperial College London, and will begin his new position on June 1.

Ardais of Lexington, Mass., has appointed Todd Golub, director for Cancer Genomics at the Whitehead/ MIT Center for Genome Research, to its scientific advisory board.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.